<DOC>
	<DOCNO>NCT01811186</DOCNO>
	<brief_summary>Objectives : 1 . Objective main interest - To assess drop-out rate cause adverse event* 6 week treatment 2 . Further objective - To assess drop-out rate cause adverse event* 1 week treatment - To assess pain reduction rate 6 week treatment baseline - To assess Euroquol ( EQ-5D ) quality life - To assess physician 's overall satisfaction - To assess subject 's overall satisfaction - To assess safety</brief_summary>
	<brief_title>An Interventional Study Compare Efficacy Tolerability With Targin® Non-malignant Chronic Pain ( GLORY )</brief_title>
	<detailed_description>Study Design ( Methodology ) : This single center , open-label , randomise , phase IV , exploratory interventional study compare efficacy tolerability current titration pattern slow titration pattern Targin® ( Oxycodone/Naloxone ) treatment moderate severe non-malignant chronic pain patient dissatisfy current analgesic medication World Health Organisation ( WHO ) step II analgesic ) . Upon provide write informed consent , subject screen study assessment perform time safety laboratory assessment , physical examination , vital sign , medical history taking , 24 hour pain intensity score . If patient eligible inclusion/exclusion criterion time visit 1 , patient randomize 1:1 ratio allocate Group A Group B. Re-screening , study drug dose interruption allow .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>Male female ≥ 20 &lt; 80 year age Patients nonmalignant chronic pain ( ≥90 day ) Patients moderate severe pain intensity control nonstrong opioid Naïve patient Oxycodone/Naloxone ( Naïve patient define treated 90 day ) Naïve patient strong opioid ( Naïve patient define treated 90 day ) Patients sign write informed consent form Women childbearing potential , defined woman physiologically capable become pregnant . Pregnant nursing ( lactate ) woman , pregnancy define state female conception termination gestation , confirm positive urine pregnancy test Patients know hypersensitivity Oxycodone/Naloxone excipients Patient need acute dose titration whose pain intensity fluctuate significantly short period accord investigator 's judgment Having use investigational drug time enrollment , within 30 day enrollment</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>moderate severe non-malignant chronic pain</keyword>
</DOC>